GlassScriptPhysician profile
Tooba Munawar
NPI 1134649817
$927.04
in general payments reported to CMS, 2019-2025
18 companies · $828 in 2025
The $828 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $99.25 · 2025: $828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $220.47 | 2024-2025 | |
| Pfizer INC. | $153.51 | 2025 | |
| Glaxosmithkline, LLC. | $107.96 | 2024-2025 | Trelegy Ellipta, Arexvy, Benlysta |
| Mallinckrodt Hospital Products INC. | $103.16 | 2024-2025 | Acthar |
| Radius Health, INC. | $45.87 | 2025 | Tymlos |
| Astrazeneca Pharmaceuticals LP | $36.37 | 2025 | Airsupra, Farxiga |
| Amgen INC. | $35.70 | 2025 | Uplizna, Krystexxa |
| Astellas Pharma US INC | $28.39 | 2025 | Veozah |
| Lilly USA, LLC | $23.76 | 2025 | Mounjaro, Zepbound |
| Verona Pharma, INC. | $22.90 | 2025 | Ohtuvayre |
| Phadia US INC. | $22.83 | 2025 | Immunocap |
| Viatris Specialty LLC | $18.70 | 2025 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $18.55 | 2025 | |
| Exact Sciences Corporation | $18.39 | 2025 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $18.27 | 2025 | Gvoke Hypopen |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $17.86 | 2025 | Rybelsus, Ozempic |
| Cequr Corporation | $17.40 | 2025 | Cequr Simplicity |
| Bioventus LLC | $16.95 | 2025 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tooba Munawar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.